Ozempic-like drug fails to treat Parkinson's disease in new study; here's what the scientists said
A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...
STAT23h
Pharmalittle: We’re reading about pharma donations to lawmakers, PBM transparency in New York, and more
In particular, the charges have targeted two lawmakers typically seen as pharma foes: Sens. Bernie Sanders (I-Vt.) and ...
I asked ChatGPT to build the perfect Stocks and Shares ISA – and here it is!
Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...
STAT4h
What happens when a rare disease drug seems to work, but the health care system doesn’t?
Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free ...
Peptide Therapeutics Market To Reach $93 Million By 2033, Flourishing At A 7.2% CAGR
Peptide Therapeutics Market was valued at USD 47.2 Million in 2023, and is expected to reach USD 93.0 Million in 2033, at a CAGR of 7.2% NEW Y ...
Zacks.com on MSN21h
Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View
Merck MRK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.72, which beat the Zacks Consensus Estimate of $1.69. In the year-ago period, management reported adjusted EPS of 3 cents ...
London close: Stocks lower as China hits back at Trump tariffs
London stocks ended lower on Tuesday as investors reacted to renewed trade tensions between the United States and China.